pI: 8.2248 |
Length (AA): 250 |
MW (Da): 26969 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
3 | 243 | 1jw9 (B) | 10 | 248 | 38.00 | 0 | 1 | 1.4532 | -0.66 |
3 | 249 | 3dbh (B) | 28 | 353 | 26.00 | 0 | 1 | 1.0022 | -0.13 |
25 | 55 | 3fbt (A) | 216 | 246 | 29.00 | 0 | 0.82 | 0.4612 | 0.26 |
27 | 62 | 4cl3 (A) | 5 | 38 | 47.00 | 0 | 0.35 | 0.4702 | 1.11 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Trophozoite. | Hon CC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Rahman HM-1 IMSS Trophozoite. | Hon CC |
Hon CC | Transcriptomics of virulent and avirulent strains |
Ortholog group members (OG5_126966)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G55130 | adenylyltransferase and sulfurtransferase MOCS3 |
Babesia bovis | BBOV_IV003870 | molybdenum cofactor synthesis protein 3 / molybdopterin synthase sulphurylase, putative |
Brugia malayi | Bm1_39490 | MoeZ/MoeB domain containing protein |
Candida albicans | CaO19.9860 | ubiquitin-activating enzyme |
Candida albicans | CaO19.2324 | ubiquitin-activating enzyme |
Caenorhabditis elegans | CELE_F42G8.6 | Protein MOC-3 |
Cryptosporidium hominis | Chro.20124 | ENSANGP00000008492 |
Cryptosporidium parvum | cgd2_1120 | putative molybdopterin synthase sulphurylase |
Dictyostelium discoideum | DDB_G0267980 | molybdenum cofactor synthesis 3 |
Drosophila melanogaster | Dmel_CG13090 | CG13090 gene product from transcript CG13090-RC |
Escherichia coli | b0826 | molybdopterin synthase sulfurylase |
Escherichia coli | b3992 | adenylyltransferase, modifies ThiS C-terminus |
Echinococcus granulosus | EgrG_000253400 | adenylyltransferase and sulfurtransferase |
Entamoeba histolytica | EHI_118040 | molybdenum cofactor synthesis protein3, putative |
Echinococcus multilocularis | EmuJ_000253400 | adenylyltransferase and sulfurtransferase |
Giardia lamblia | GL50803_12853 | Molybdopterin biosynthesis MoeB protein |
Homo sapiens | 27304 | molybdenum cofactor synthesis 3 |
Leishmania braziliensis | LbrM.27.1800 | molybdopterin synthase sulphurylase-like protein, putative |
Leishmania donovani | LdBPK_271570.1 | molybdopterin synthase sulphurylase-like protein, putative |
Leishmania infantum | LinJ.27.1570 | molybdopterin synthase sulphurylase-like protein, putative |
Leishmania mexicana | LmxM.27.1670 | molybdopterin synthase sulphurylase-like protein, putative |
Loa Loa (eye worm) | LOAG_00263 | hypothetical protein |
Mycobacterium leprae | ML0817 | PROBABLE MOLYBDENUM COFACTOR BIOSYNTHESIS PROTEIN MOEB1 (MPT-SYNTHASE SULFURYLASE) (MOLYBDOPTERIN SYNTHASE SULPHURYLASE) |
Mus musculus | ENSMUSG00000074576 | molybdenum cofactor synthesis 3 |
Mycobacterium tuberculosis | Rv3116 | Probable molybdenum cofactor biosynthesis protein MoeB2 (MPT-synthase sulfurylase) (molybdopterin synthase sulphurylase) |
Mycobacterium tuberculosis | Rv3206c | Probable molybdenum cofactor biosynthesis protein MoeB1 (MPT-synthase sulfurylase) (molybdopterin synthase sulphurylase) |
Mycobacterium ulcerans | MUL_2527 | molybdopterin biosynthesis-like protein MoeZ |
Neospora caninum | NCLIV_049260 | hypothetical protein |
Oryza sativa | 9268394 | Os02g0804600 |
Oryza sativa | 4329515 | Os02g0525400 |
Plasmodium berghei | PBANKA_1141200 | ubiquitin-activating enzyme, putative |
Plasmodium falciparum | PF3D7_1365400 | ubiquitin-activating enzyme |
Plasmodium knowlesi | PKNH_1105900 | ubiquitin-activating enzyme, putative |
Plasmodium vivax | PVX_115230 | ubiquitin-activating enzyme, putative |
Plasmodium yoelii | PY02846 | molybdopterin biosynthesis protein MoeB |
Saccharomyces cerevisiae | YHR111W | Uba4p |
Schistosoma japonicum | Sjp_0041970 | ko:K03751 molybdopterin biosynthesis protein MoeB, putative |
Schistosoma mansoni | Smp_035280 | ubiquitin-activating enzyme E1 |
Schmidtea mediterranea | mk4.004929.00 | Adenylyltransferase and sulfurtransferase MOCS3 |
Schmidtea mediterranea | mk4.085557.01 | |
Schmidtea mediterranea | mk4.000957.11 | Adenylyltransferase and sulfurtransferase MOCS3 |
Trypanosoma brucei gambiense | Tbg972.11.2580 | molybdopterin synthase sulphurylase protein, putative |
Trypanosoma brucei | Tb927.11.2330 | molybdopterin synthase sulphurylase protein, putative |
Trypanosoma congolense | TcIL3000.11.2090 | molybdopterin synthase sulphurylase protein, putative |
Trypanosoma cruzi | TcCLB.506127.80 | molybdopterin synthase sulphurylase-like protein, putative |
Toxoplasma gondii | TGME49_212100 | ThiF family protein |
Theileria parva | TP01_1017 | UBA/THIF-type NAD/FAD binding protein, putative |
Trichomonas vaginalis | TVAG_318990 | ubiquitin-activating enzyme E1c, putative |
Trichomonas vaginalis | TVAG_301440 | ubiquitin-activating enzyme E1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu3169 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.22.0008 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.22.0008 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.22.0008 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.22.0008 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b0826 | Escherichia coli | non-essential | goodall |
b3992 | Escherichia coli | non-essential | goodall |
PBANKA_1141200 | Plasmodium berghei | Essential | plasmo |
TGME49_212100 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.